Evaluating the efficacy of allogeneic adipose-derived mesenchymal stem cells in hyaline cartilage regeneration in a dog model

  • Đặng Văn Huy Bệnh viện Quân y 110, Quân khu 1
  • Lê Hữu Phương Anh Bệnh viện TWQĐ 108
  • Phạm Công Nguyên Bệnh viện TWQĐ 108
  • Nguyễn Hải Anh Bệnh viện TWQĐ 108
  • Ngô Thị Minh Hạnh Bệnh viện TWQĐ 108
  • Phan Huy Cảnh Bệnh viện TWQĐ 108
  • Ngô Thị Hạnh Học viện Nông nghiệp Việt Nam
  • Nguyễn Thị Hương Học viện Nông nghiệp Việt Nam
  • Nguyễn Thế Hoàng Bệnh viện TWQĐ 108
  • Trần Thị Huyền Trang Bệnh viện TWQĐ 108

Main Article Content

Keywords

Cartilage damage, cartilage regeneration, MSC, hyaline, experimental model

Abstract

Objective: Cartilage damage is frequently recognized as a source of knee arthritis, which can cause many long-term complications. Among existing cartilage treatment options, mesenchymal stem cells (MSCs) have emerged as promising treatments for cartilage regeneration. This study aimed to comprehensively evaluate the cartilage regeneration ability of adipose-derived allogeneic AD-MSCs for acute cartilage defects in an experimental model. Subject and method: This model is based on surgically applied mechanical articular cartilage damage of all four limb joints of sixteen dogs selected for the study. They were symmetrical randomized to a single infusion either of placebo or (2´106 cells) allogeneic AD-MSCs and followed for 3 months. The effectiveness of treatment was validated by gross anatomy scores and histopathology scores. Result: Higher macroscopic were observed in MSCs-treated joints throughout the study period, with significant differences noted at 3 months (9.5 ± 0.6 vs 4.3 ± 1.5, p<0.05) and 6 months (8.7 ± 1.2 vs 4.6 ± 1.7, p<0.05), respectively. There was a significantly higher amount of hyaline cartilage in the MSC treatment group than in the placebo group. No adverse event was observed during the 3-month follow-up after treatment. Conclusion: Allogeneic AD-MSCs showed efficiency in producing hyaline cartilage, which might be more advanced than the current surgical techniques that deliver only fibrocartilage. The results suggest a promising application of MSC treatment for articular cartilage defects

Article Details

References

1. Armiento AR, Alini M, Stoddart MJ (2019) Articular fibrocartilage - Why does hyaline cartilage fail to repair? Advanced drug delivery reviews 146: 289-305. doi: https://doi.org/10.1016/j.addr.2018.12.015.
2. Cong B, Sun T, Zhao Y, Chen M (2023) Current and novel therapeutics for articular cartilage repair and regeneration. Ther Clin Risk Manag 19: 485-502. doi:10.2147/TCRM.S410277.
3. Chen M, Jiang Z, Zou X, You X, Cai Z, Huang J (2024) Advancements in tissue engineering for articular cartilage regeneration. Heliyon 10(3):25400. doi:10.1016/j.heliyon.2024.e25400.
4. Chu CR, Szczodry M, Bruno S (2010) Animal models for cartilage regeneration and repair. Tissue Eng Part B Rev 16(1): 105-115. doi:10.1089/ten.TEB.2009.0452.
5. Marijnissen AC, van Roermund PM, TeKoppele JM, Bijlsma JW, Lafeber FP (2002) The canine 'groove' model, compared with the ACLT model of osteoarthritis. Osteoarthritis and cartilage 10(2): 145-155. doi:10.1053/joca.2001.0491.
6. Li L, Duan X, Fan Z et al (2018) Mesenchymal stem cells in combination with hyaluronic acid for articular cartilage defects. Scientific Reports 8(1): 9900. doi:10.1038/s41598-018-27737-y.
7. van den Borne MP, Raijmakers NJ, Vanlauwe J et al (2007) International Cartilage Repair Society (ICRS) and Oswestry macroscopic cartilage evaluation scores validated for use in Autologous Chondrocyte Implantation (ACI) and microfracture. Osteoarthritis and cartilage 15(12): 1397-1402. doi:10.1016/j.joca.2007.05.005.
8. Cook JL, Kuroki K, Visco D, Pelletier JP, Schulz L, Lafeber FP (2010) The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the dog. Osteoarthritis and cartilage 18(3): 66-79. doi:10.1016/j.joca.2010.04.017.
9. Mainil-Varlet P, Aigner T, Brittberg M et al (2003) Histological assessment of cartilage repair: a report by the Histology Endpoint Committee of the International Cartilage Repair Society (ICRS). J Bone Joint Surg Am 85-A Suppl 2: 45-57.
10. O'Driscoll SW, Keeley FW, Salter RB (1986) The chondrogenic potential of free autogenous periosteal grafts for biological resurfacing of major full-thickness defects in joint surfaces under the influence of continuous passive motion. An experimental investigation in the rabbit. J Bone Joint Surg Am 68(7): 1017-1035.
11. Wakitani S, Goto T, Pineda SJ, Young RG, Mansour JM, Caplan AI, Goldberg VM (1994) Mesenchymal cell-based repair of large, full-thickness defects of articular cartilage. The Journal of bone and joint surgery American 76(4): 579-592. doi:10.2106/00004623-199404000-00013.
12. Ma W, Liu C, Wang S, Xu H, Sun H, Fan X (2020) Efficacy and safety of intra-articular injection of mesenchymal stem cells in the treatment of knee osteoarthritis: A systematic review and meta-analysis. Medicine 99(49):e23343. doi:10.1097/md.0000000000023343.
13. Jia Z, Liu Q, Liang Y, et al (2018) Repair of articular cartilage defects with intra-articular injection of autologous rabbit synovial fluid-derived mesenchymal stem cells. Journal of Translational Medicine 16(1):123. doi:10.1186/s12967-018-1485-8.
14. Wei P, Bao R (2022) Intra-Articular Mesenchymal Stem Cell Injection for Knee Osteoarthritis: Mechanisms and Clinical Evidence. Int J Mol Sci 24(1): 59. doi: 10.3390/ijms24010059.